These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8445043)

  • 1. Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma.
    Mathiot C; Teillaud JL; Elmalek M; Mosseri V; Euller-Ziegler L; Daragon A; Grosbois B; Michaux JL; Facon T; Bernard JF
    J Clin Immunol; 1993 Jan; 13(1):41-8. PubMed ID: 8445043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD16 in plasma cell dyscrasias.
    Mathiot C; Galon J; Tartour E; Teillaud JL; Facon T; Bataille R; Fridman WH; Sautès C
    Leuk Lymphoma; 1999 Feb; 32(5-6):467-74. PubMed ID: 10048419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums].
    Mathiot C; Grosbois B; Teillaud JL; Tartour E; Mosseri V; Euller-Ziegler L; Daragon A; Michaux JL; Facon T; Bernard JF
    Rev Med Interne; 1993; 14(10):960. PubMed ID: 8009056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma.
    Kaiser U; Oldenburg M; Jaques G; Auerbach B; Havemann K
    Ann Hematol; 1996 Sep; 73(3):121-6. PubMed ID: 8841099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum beta 2-microglobulin in patients with monoclonal gammopathies.
    Di Giovanni S; Valentini G; Ravazzolo E; Carducci P; Giallonardo P; Maschio C
    Int J Biol Markers; 1987; 2(3):169-72. PubMed ID: 3131451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions.
    Moldovan I; Galon J; Maridonneau-Parini I; Roman Roman S; Mathiot C; Fridman WH; Sautès-Fridman C
    Immunol Lett; 1999 May; 68(1):125-34. PubMed ID: 10397167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
    Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16.
    Hoover RG; Lary C; Page R; Travis P; Owens R; Flick J; Kornbluth J; Barlogie B
    J Clin Invest; 1995 Jan; 95(1):241-7. PubMed ID: 7529259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity.
    Papadaki H; Kyriakou D; Foudoulakis A; Markidou F; Alexandrakis M; Eliopoulos GD
    Acta Haematol; 1997; 97(4):191-5. PubMed ID: 9158660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum neopterin concentration as indicator of disease severity and poor survival in multiple myeloma.
    Boccadoro M; Battaglio S; Omedè P; Palumbo AP; Fusaro A; Frieri R; Gallone G; Polloni R; Mosso R; De Filippi PG
    Eur J Haematol; 1991 Oct; 47(4):305-9. PubMed ID: 1954991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of patients with monoclonal gammopathy of undetermined significance is mandatory for a reliable use of interleukin-6 and other nonspecific multiple myeloma serum markers.
    Greco C; Ameglio F; Alvino S; Cianciulli AM; Giovannelli M; Mattei F; Vitelli G; Venturo I; Lopez M; Gandolfo GM
    Acta Haematol; 1994; 92(1):1-7. PubMed ID: 7985475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell frequency and serum cytokine levels in monoclonal gammopathies: correlation of bone marrow granular lymphocytes to prognosis.
    Sawanobori M; Suzuki K; Nakagawa Y; Inoue Y; Utsuyama M; Hirokawa K
    Acta Haematol; 1997; 98(3):150-4. PubMed ID: 9352746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS).
    Mathiot C; Mary JY; Tartour E; Facon T; Monconduit M; Grosbois B; Pollet JP; Michaux JL; Euller Ziegler L; Sautès C; Bataille R; Fridman WH
    Br J Haematol; 1996 Dec; 95(4):660-5. PubMed ID: 8982042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell activity in monoclonal gammopathies: relation to disease activity.
    Osterborg A; Nilsson B; Björkholm M; Holm G; Mellstedt H
    Eur J Haematol; 1990 Sep; 45(3):153-7. PubMed ID: 1699786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis].
    Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
    Vnitr Lek; 1991 Apr; 37(4):342-51. PubMed ID: 2053304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors.
    Aref S; Goda T; El-Sherbiny M
    Hematology; 2003 Aug; 8(4):221-8. PubMed ID: 12911939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
    Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
    Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic significance of beta-2-microglobulin in multiple myeloma].
    Podol'tseva EI; Morozova EV; Almazov VA
    Vopr Onkol; 1996; 42(4):32-5. PubMed ID: 8928455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum beta 2-microglobulin levels in multiple myeloma and monoclonal gammapathy of undetermined significance: a clinical study of 55 patients.
    Chelazzi G; Senaldi G
    Ric Clin Lab; 1986; 16(1):53-8. PubMed ID: 3090677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum levels of beta 2-microglobulin in monoclonal gammopathies].
    Pasqualetti P
    Ann Ital Med Int; 1987; 2(1):31-6. PubMed ID: 3152791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.